Medicines, 2021
Shortlist up to four to read them side by side.
1,016 medicine recalls FDA’s Enforcement Report published in 2021, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
1,016of 1,016 medicine recallsshown with your filters
The list
- Medicine recall LOTRIMIN AF (Tolnaftate 1%) DAILY PREVENTION deodorant powder spray cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. Class IIFDA’s classNov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Lotrimin AF (Miconazole nitrate 2%) Liquid Spray cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. Class IIFDA’s classNov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Tinactin (Tolnaftate 1%) DEODORANT POWDER SPRAY cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. Class IIFDA’s classNov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Tinactin (Tolnaftate 1%) LIQUID SPRAY cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. Class IIFDA’s classNov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Tinactin (Tolnaftate 1%) JOCK ITCH POWDER SPRAY cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. Class IIFDA’s classNov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Tinactin (Tolnaftate 1%) POWDER SPRAY cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. Class IIFDA’s classNov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall LOTRIMIN AF (Miconazole nitrate 2%) Deodorant Powder Spray Chemical Contamination: presence of benzene FDA Class I, its most serious class Class IFDA’s class (needs attention)Nov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall LOTRIMIN AF, (Miconazole nitrate 2%), Jock Itch, Powder Spray Chemical Contamination: presence of benzene FDA Class I, its most serious class Class IFDA’s class (needs attention)Nov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall LOTRIMIN AF, (Miconazole nitrate 2%), Powder Spray Chemical Contamination: presence of benzene FDA Class I, its most serious class Class IFDA’s class (needs attention)Nov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Lotrimin AF (Tolnaftate 1%) Daily Prevention deodorant powder spray Chemical Contamination: presence of benzene FDA Class I, its most serious class Class IFDA’s class (needs attention)Nov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Tinactin (Tolnaftate 1%) DEODORANT POWDER SPRAY Chemical Contamination: presence of benzene FDA Class I, its most serious class Class IFDA’s class (needs attention)Nov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Tinactin (Tolnaftate 1%) LIQUID SPRAY Chemical Contamination: presence of benzene FDA Class I, its most serious class Class IFDA’s class (needs attention)Nov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Tinactin (Tolnaftate 1%) JOCK ITCH POWDER SPRAY Chemical Contamination: presence of benzene FDA Class I, its most serious class Class IFDA’s class (needs attention)Nov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Tinactin (Tolnaftate 1%) POWDER SPRAY Chemical Contamination: presence of benzene FDA Class I, its most serious class Class IFDA’s class (needs attention)Nov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall LOTRIMIN AF (Tolnaftate 1%) DAILY PREVENTION deodorant powder spray cGMP Deviations: LOTRIMIN AF (Tolnaftate 1%) manufactured at the same facility where other lots were found to be contaminated with benzene. Class IIFDA’s classNov 24, 2021in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 24, 2021ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Acetaminophen Oral Suspension, 160 mg/5 mL cGMP Deviations: Product manufactured with contaminated raw ingredient. Class IIFDA’s classNov 17, 2021in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Acetaminophen Oral Suspension, 325 mg/10.15 mL cGMP Deviations: Product manufactured with contaminated raw ingredient. Class IIFDA’s classNov 17, 2021in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Cetirizine hydrochloride, 10 mg tablets, 90-count bottle Labeling: Not Elsewhere classified: Product was relabeled as 90 tablet count product although it was a manufacturer in a box with 30 tablet count tablets. Class IIIFDA’s classNov 17, 2021in FDA’s Enforcement Report4 statesnamed in where it went PublishedNov 17, 2021ClassClass IIIStatusTerminatedWhereFlorida, Indiana, Minnesota and Wisconsin
- Medicine recall Estradiol Valerate 20 mg/mL in Ethyl Oleate Inj. 20 mg/mL Injection in vials Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall (WELL’S LIPO-LEAN)INOSITOL/CHOLINE/B-COMP+LEUCINE+CARN+ CHROM+LIDO 25MG/25MG/1.5MG/25MG/25MCG/10MG INJECTABLE… Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall ALPROSTADIL 22.5MCG/ML 22.5MCG/ML INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall ALPROSTADIL 22MCG/ML 22MCG/ML INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall ALPROSTADIL 25MCG/ML 25MCG/ML INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall ALPROSTADIL 30MCG/ML INJ 30MCG/ML INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall ALPROSTADIL 32MCG/ML 32MCG/ML INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall ALPROSTADIL 40MCG/ML INJ 40MCG/ML INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall ALPROSTADIL 45MCG/ML 45MCG/ML INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall B COMPLEX INJ CMP-NO B12, NO LIDOCAINE INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall BI-MIX PAPAVERINE 40/PHENTOLAMINE 2 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall BLUE TREE LIPO EXTREME (/W METHYLCOBALAMIN) INJECTION INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall CJC-1295 4MG/IPAMORELIN 4MG VIAL 4MG/4MG INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall ESTRADIOL VALERATE 10MG/ML IN ETHYL OLEATE 10MG/ML INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall ESTRADIOL VALERATE 30MG/ML INJ #1 IN ETHYL OLEATE OIL INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall ESTRADIOL VALERATE 40MG/ML IN ETHYL OLEATE INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall ESTRADIOL VALERATE 50MG/ML IN ETHYL OLEATE INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall ESTRADIOL VALERATE 50MG/ML INJ #2 INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall ESTRADIOL VALERATE 5MG/ML IN ETHYL OLEATE 5MG/ML INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall GOAL-GLUTAMINE 75MG/ORNITHINE 75MG/ARGININE 150MG/LYSINE 150MG+LIDOCAINE 10MG/ML… Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall HYDROXOCOBALAMIN 1,000MCG/ML INJ VIAL 1,000MCG/ML INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall HYDROXOCOBALAMIN 5,000MCG/ML INJ 5,000MCG/ML INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall IC B COMPLEX INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall IVME HCG VITAMIN B INJ (CONTAINS NO HCG) INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall IVME SUPER B INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall L-CARNITINE 250MG/ML INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall LEUCINE 10MG/ ISOLEUCINE 15MG/ VALINE 40MG/ML (BCAA) INJ 10MG/15MG/40MG/ML INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall MEDROXYPROGESTERONE ACET 150MG/ML SUSP (PF) 150MG/ML SUSPENSION Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall METHYLCOBALAMIN 1MG/ML Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall METHYLCOBALAMIN 5MG/ML Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.